This study demonstrated that a novel serum marker combination of EGF, log10 IL-8, log10 MCP-1, and log10 tPSA significantly improved the predictive potential of tPSA alone to identify patients with PCa. Here, CXCL8 is linked to posterior cortical atrophy.